[1]CurrentPatentAssignee:ABBVIEINC-US2005/222175,2005,A1
[1]CurrentPatentAssignee:ABBVIEINC-US2005/222175,2005,A1
[2]CurrentPatentAssignee:ABBVIEINC-US2005/222176,2005,A1
[1]CurrentPatentAssignee:ABBVIEINC-US2005/222176,2005,A1
[1]Locationinpatent:schemeortableHoriuchi,Takao;Chiba,Jun;Uoto,Kouichi;Soga,Tsunehiko[BioorganicandMedicinalChemistryLetters,2009,vol.19,#2,p.305-308]
[1]Locationinpatent:experimentalpartHoriuchi,Takao;Takeda,Yasuyuki;Haginoya,Noriyasu;Miyazaki,Masaki;Nagata,Motoko;Kitagawa,Mayumi;Akahane,Kouichi;Uoto,Kouichi[ChemicalandPharmaceuticalBulletin,2011,vol.59,#8,p.991-1002]
[2]Locationinpatent:schemeortableHoriuchi,Takao;Chiba,Jun;Uoto,Kouichi;Soga,Tsunehiko[BioorganicandMedicinalChemistryLetters,2009,vol.19,#2,p.305-308]
Title: Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.
Journal: Nature chemical biology 20120129